New COVID vaccine shows promise in both needle and nasal spray forms

NCT ID NCT05205746

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a single dose of a new COVID-19 vaccine (AVX/COVID-12) in 158 healthy adults who already had some immunity to the virus. The vaccine was given either as an injection or a nasal spray to see which route worked better and was safe. Researchers measured antibody and T-cell responses to understand how well the vaccine boosted protection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARS-COV-2 INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CAIMED Investigación en Salud S.A. de C.V.

    Mexico City, Mexico City, 06760, Mexico

  • Centro Mexicano de Estudios Clínicos CEMDEC SA de CV

    Mexico City, Mexico City, 06100, Mexico

  • Oaxaca Site Management Organization S.C.

    Oaxaca City, Oaxaca, 68000, Mexico

  • Unidad Médico Familiar No. 20 Instituto Mexicano del Seguro Social

    Mexico City, Mexico City, 07760, Mexico